• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Stephen E. Sallan, MD

Publications

  • Reynolds C, Roderick JE, LaBelle JL, Bird G, Mathieu R, Bodaar K, Colon D, Pyati U, Stevenson KE, Qi J, Harris M, Silverman LB, Sallan SE, Bradner JE, Neuberg DS, Look AT, Walensky LD, Kelliher MA, Gutierrez A.Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.Leukemia. 2014 Sep(9):1819-27.
    24552990
  • Ewer M, Gianni L, Pane F, Sandri MT, Steiner RK, Wojnowski L, Yeh ET, Carver JR, Lipshultz SE, Minotti G, Armstrong GT, Cardinale D, Colan SD, Darby SC, Force TL, Kremer LC, Lenihan DJ, Sallan SE, Sawyer DB, Suter TM, Swain SM, van Leeuwen FE.Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).Ecancermedicalscience. 2014;8:433.
    24932213
  • Ben Tanfous M, Sharif-Askari B, Ceppi F, Laaribi H, Gagné V, Rousseau J, Labuda M, Silverman LB, Sallan SE, Neuberg D, Kutok JL, Sinnett D, Laverdière C, Krajinovic M.Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.Clin Cancer Res. 2014 Jun 6.
    24907114
  • Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend EC, van Bodegom D, Day TA, Wu SC, Liu H, Yoda A, Alexe G, Schinzel AC, Sullivan TJ, Malinge S, Taylor JE, Stegmaier K, Jaffe JD, Bustin M, te Kronnie G, Izraeli S, Harris MH, Stevenson KE, Neuberg D, Silverman LB, Sallan SE, Bradner JE, Hahn WC, Crispino JD, Pellman D, Weinstock DM.Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation.Nat Genet. 2014 Jun(6):618-23.
    24747640
  • Mar BG, Bullinger LB, McLean KM, Grauman PV, Harris MH, Stevenson K, Neuberg DS, Sinha AU, Sallan SE, Silverman LB, Kung AL, Lo Nigro L, Ebert BL, Armstrong SA.Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia.Nat Commun. 2014;5:3469.
    24662245
  • Roderick JE, Tesell J, Shultz LD, Brehm MA, Greiner DL, Harris MH, Silverman LB, Sallan SE, Gutierrez A, Look AT, Qi J, Bradner JE, Kelliher MA.c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.Blood. 2014 Feb 13;123(7):1040-50.
    24394663
  • Sanchez R, St-Cyr J, Lalonde ME, Healy J, Richer C, Gagné V, Laverdière C, Silverman LB, Sallan SE, Neuberg D, Kutok JL, Kritikou EA, Krajinovic M, Sinnett D.Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia.Haematologica. 2014 Feb;99(2):314-21.
    24038028
  • Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, Hudson MM, Kremer LC, Landy DC, Miller TL, Oeffinger KC, Rosenthal DN, Sable CA, Sallan SE, Singh GK, Steinberger J, Cochran TR, Wilkinson JD, .Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association.Circulation. 2013 Oct 22;128(17):1927-95.
    24081971
  • Lipshultz SE, Lipsitz SR, Kutok JL, Miller TL, Colan SD, Neuberg DS, Stevenson KE, Fleming MD, Sallan SE, Franco VI, Henkel JM, Asselin BL, Athale UH, Clavell LA, Michon B, Laverdiere C, Larsen E, Kelly KM, Silverman LB.Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.Cancer. 2013 Oct 1;119(19):3555-62.
    23861158
  • Gagné V, Rousseau J, Labuda M, Sharif-Askari B, Brukner I, Laverdière C, Ceppi F, Sallan SE, Silverman LB, Neuberg D, Kutok JL, Sinnett D, Krajinovic M.Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.Clin Cancer Res. 2013 Sep 15;19(18):5240-9.
    23908358
  • Waber DP, McCabe M, Sebree M, Forbes PW, Adams H, Alyman C, Sands SA, Robaey P, Romero I, Routhier MÈ, Girard JM, Sallan SE, Silverman LB.Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.Pediatr Blood Cancer. 2013 Nov;60(11):1785-91.
    23832430
  • Place AE, Frederick NN, Sallan SE.Therapeutic approaches to haematological malignancies in adolescents and young adults.British Journal of Haematology. 2013 Sep 6.
    24007213
  • Vrooman LM, Stevenson KE, Supko JG, O'Brien J, Dahlberg SE, Asselin BL, Athale UH, Clavell LA, Kelly KM, Kutok JL, Laverdière C, Lipshultz SE, Michon B, Schorin M, Relling MV, Cohen HJ, Neuberg DS, Sallan SE, Silverman LB.Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.J Clin Oncol. 2013 Mar 20;31(9):1202-10.
    23358966
  • Lipshultz SE, Miller TL, Lipsitz SR, Neuberg DS, Dahlberg SE, Colan SD, Silverman LB, Henkel JM, Franco VI, Cushman LL, Asselin BL, Clavell LA, Athale U, Michon B, Laverdière C, Schorin MA, Larsen E, Usmani N, Sallan SE, .Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.Pediatrics. 2012 Dec;130(6):1003-11.
    23166343
  • Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA.Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma.Clin Cancer Res. 2012 Oct 15;18(20):5773-5779.
    22896655
  • Merryman R, Stevenson KE, Gostic WJ, Neuberg D, O'Brien J, Sallan SE, Silverman LB.Asparaginase-associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia.Pediatr Blood Cancer. 2012 Nov;59(5):925-7.
    22532399
  • Monje M, Thomason ME, Rigolo L, Wang Y, Waber DP, Sallan SE, Golby AJ.Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia.Pediatr Blood Cancer. 2012 Aug 8.
    22887801
  • Goldberg JM, Scully RE, Sallan SE, Lipshultz SE.Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.J. Pediatr. Hematol. Oncol. 2012 Jul;34(5):395-7.
    22584777
  • Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, Agoston ES, Reynoird N, Khochbin S, Ince TA, Christie A, Janeway KA, Vargas SO, Perez-Atayde AR, Aster JC, Sallan SE, Kung AL, Bradner JE, French CA.Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming.Cancer Res. 2011 Apr 1;71(7):2686-96.
    21447744
  • Batista A, Barata JT, Raderschall E, Sallan SE, Carlesso N, Nadler LM, Cardoso AA.Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.Exp Hematol. 2011 Apr;39(4):457-472.e3.
    21277936
  • Grace RF, Dahlberg SE, Neuberg D, Sallan SE, Connors JM, Neufeld EJ, Deangelo DJ, Silverman LB.The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.British Journal of Haematology. 2011 Feb;152(4):452-9.
    21210774
  • Lipshultz SE, Scully RE, Lipsitz SR, Sallan SE, Silverman LB, Miller TL, Barry EV, Asselin BL, Athale U, Clavell LA, Larsen E, Moghrabi A, Samson Y, Michon B, Schorin MA, Cohen HJ, Neuberg DS, Orav EJ, Colan SD.Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.Lancet Oncol. 2010 Oct;11(10):950-61.
    20850381
  • Gutierrez A, Dahlberg SE, Neuberg DS, Zhang J, Grebliunaite R, Sanda T, Protopopov A, Tosello V, Kutok J, Larson RS, Borowitz MJ, Loh ML, Ferrando AA, Winter SS, Mullighan CG, Silverman LB, Chin L, Hunger SP, Sallan SE, Look AT.Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.J Clin Oncol. 2010 Aug 20;28(24):3816-23.
    20644084
  • Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S, Neuberg D, Protopopov A, Winter SS, Larson RS, Borowitz MJ, Silverman LB, Chin L, Hunger SP, Jamieson C, Sallan SE, Look AT.Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.Blood. 2010 Apr 8;115(14):2845-51.
    20124220
  • Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Laverdière C, Michon B, Schorin M, Schwartz CL, O'Brien JE, Cohen HJ, Sallan SE.Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.Blood. 2010 Feb 18;115(7):1351-3.
    20007809
  • Stam RW, Den Boer ML, Schneider P, de Boer J, Hagelstein J, Valsecchi MG, de Lorenzo P, Sallan SE, Brady HJ, Armstrong SA, Pieters R.Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.Blood. 2010 Feb 4;115(5):1018-25.
    19965632
  • Vrooman LM, Supko JG, Neuberg DS, Asselin BL, Athale UH, Clavell L, Kelly KM, Laverdière C, Michon B, Schorin M, Cohen HJ, Sallan SE, Silverman LB.Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.Pediatr Blood Cancer. 2010 Feb;54(2):199-205.
    19672973
  • Al-Shakfa F, Dulucq S, Brukner I, Milacic I, Ansari M, Beaulieu P, Moghrabi A, Laverdière C, Sallan SE, Silverman LB, Neuberg D, Kutok JL, Sinnett D, Krajinovic M.DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia.Clin Cancer Res. 2009 Nov 15;15(22):6931-8.
    19861437
  • Sallan SE, Schrappe M, Silverman LB.Treating childhood leukemia without cranial irradiation.N Engl J Med. 2009 Sep 24;361(13):1310; author reply 1311-2.
    19776415
  • Gutierrez A,Sanda T,Grebliunaite R,Carracedo A,Salmena L,Ahn Y,Dahlberg S,Neuberg D,Moreau LA,Winter SS,Larson R,Zhang J,Protopopov A,Chin L,Pandolfi PP,Silverman LB,Hunger SP,Sallan SE,Look AT.High frequency of PTEN, PI3K and AKT abnormalities in T cell acute lymphoblastic leukemia.Blood. 2009 Jul 16;114(3):647-50.
    19458356
  • Kearney SL,Dahlberg SE,Levy DE,Voss SD,Sallan SE,Silverman LB.Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.Pediatr Blood Cancer. 2009 Aug;53(2):162-7.
    19405141
  • Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, Yasui Y, Robison LL, Neglia JP.Twenty five year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.Blood. 2008 Jun 15;111(12):5515-23.
    18334672
  • Barry EV, Vrooman LM, Dahlberg SE, Neuberg DS, Asselin BL, Athale UH, Clavell LA, Larsen EC, Moghrabi A, Samson Y, Schorin MA, Cohen HJ, Lipshultz SE, Sallan SE, Silverman LB.Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.J Clin Oncol. 2008 Mar 1;26(7):1106-11.
    18309945
  • Del Gaizo Moore V, Schlis KD, Sallan SE, Armstrong SA, Letai A.BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.Blood. 2008 Feb 15;111(4):2300-9.
    18056841
  • Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Neuberg DS, Sallan SE, Silverman LB.Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.J Clin Oncol. 2007 Nov 1;25(31):4914-21.
    17971588
  • Zhou J, Goldwasser MA, Li A, Dahlberg SE, Neuberg D, Wang H, Dalton V, McBride KD, Sallan SE, Silverman LB, Gribben JG.Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL consortium protocol 95-01.Blood. 2007 Sep 1;110(5):1607-11.
    17485550
  • Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE, Silverman LB.Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.J Clin Oncol. 2007 Mar 1;25(7):813-9.
    17327603
  • Tissing WJ, den Boer ML, Meijerink JP, Menezes RX, Swagemakers S, van der Spek PJ, Sallan SE, Armstrong SA, Pieters R.Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.Blood. 2007 May 1;109(9):3929-35.
    17218380
  • Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, Golub TR, Armstrong SA.Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.Cancer Cell. 2006 Oct;10(4):331-42.
    17010674
  • Moghrabi A, Levy DE, Asselin B, Barr R, Clavell L, Hurwitz C, Samson Y, Schorin M, Dalton VK, Lipshultz SE, Neuberg DS, Gelber RD, Cohen HJ, Sallan SE, Silverman LB.Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.Blood. 2007 Feb 1;109(3):896-904.
    17003366
  • Veiga JP, Costa LF, Sallan SE, Nadler LM, Cardoso AA.Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.Exp Hematol. 2006 May;34(5):610-21.
    16647567
  • Loh ML, Goldwasser MA, Silverman LB, Poon WM, Vattikuti S, Cardoso A, Neuberg DS, Shannon KM, Sallan SE, Gilliland DG.Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.Blood. 2006 Jun 1;107(11):4508-13.
    16493009
  • Stam RW, den Boer ML, Passier MM, Janka-Schaub GE, Sallan SE, Armstrong SA, Pieters R.Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.Leukemia. 2006 Feb;20(2):264-71.
    16357833
  • Maia S, Haining WN, Ansn S, Xia Z, Armstrong SA, Seth NP, Ghia P, den Boer ML, Pieters R, Sallan SE, Nadler LM, Cardoso AA.Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.Cancer Res. 2005 Nov 1;65(21):10050-8.
    16267031
  • Li A, Goldwasser MA, Zhou J, Armstrong SA, Wang H, Dalton V, Fletcher JA, Sallan SE, Silverman LB, Gribben JG.Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias.Br J Haematol. 2005 Oct;131(2):185-92.
    16197448
  • Stam RW, den Boer ML, Schneider P, Nollau P, Horstmann M, Beverloo HB, van der Voort E, Valsecchi MG, de Lorenzo P, Sallan SE, Armstrong SA, Pieters R.Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.Blood. 2005 Oct 1;106(7):2484-90.
    15956279
  • Haining WN, Neuberg DS, Keczkemethy HL, Evans JW, Rivoli S, Gelman R, Rosenblatt HM, Shearer WT, Guenaga J, Douek DC, Silverman LB, Sallan SE, Guinan EC, Nadler LM.Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.Blood. 2005 Sep 1;106(5):1749-54.
    15920008
  • Li FP, Fletcher JA, Heinrich MC, Garber JE, Sallan SE, Curiel-Lewandrowski C, Duensing A, van de Rijn M, Schnipper LE, Demetri GD.Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.J Clin Oncol. 2005 Apr 20;23(12):2735-43.
    15837988
  • Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD.Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.J Clin Oncol. 2005 Apr 20;23(12):2629-36.
    15837978
  • Haining WN, Cardoso AA, Keczkemethy HL, Fleming M, Neuberg D, DeAngelo DJ, Stone RM, Galinsky I, Silverman LB, Sallan SE, Nadler LM, Guinan EC.Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia.Exp Hematol. 2005 Mar;33(3):286-94.
    15730852
  • Li A, Rue M, Zhou J, Wang H, Goldwasser MA, Neuberg D, Dalton V, Zuckerman D, Lyons C, Silverman LB, Sallan SE, Gribben JG.Utilization of Ig Heavy-Chain Variable, Diversity and Joining Gene Segments in Children with B-lineage Acute Lymphoblastic Leukemia: Implications for the Mechanisms of VDJ Recombination and for Pathogenesis.Blood. 2004 Jun 15;103(12):4602-9.
    15010366
  • Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, Chan S, Li C, Rowitch DH, Wong WH, DePinho RA.Molecular diversity of astrocytes with implications for neurological disorders.Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8384-9.
    15155908
  • Armstrong SA, Mabon ME, Silverman LB, Li A, Gribben JG, Fox EA, Sallan SE, Korsmeyer SJ.FLT3 mutations in childhood acute lymphoblastic leukemia.Blood. 2004 May 1;103(9):3544-6.
    14670924
  • Barata JT, Boussiotis VA, Yunes JA, Ferrando AA, Moreau LA, Veiga JP, Sallan SE, Look AT, Nadler LM, Cardoso AA.IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.Blood. 2004 Mar 1;103(5):1891-900.
    14615384
  • Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL.Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.J Clin Oncol. 2003 Oct 1;21(19):3616-22.
    14512392
  • Li A, Zhou J, Zuckerman D, Rue M, Dalton V, Lyons C, Silverman LB, Sallan SE, Gribben JG.Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residu.Blood. 2003 Dec 15;102(13):4520-6.
    12946997
  • Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Tarbell NJ, Sallan SE, Cohen LE.Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.J Clin Oncol. 2003 Aug 1;21(15):2953-60.
    12885815
  • Silverman LB, Sallan SE.Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment.Curr Opin Hematol. 2003 Jul;10(4):290-6.
    12799535
  • Fleming MD, Pinkus JL, Alexander SW, Tam C, Loda M, Sallan SE, Nichols KE, Carpentieri DF, Pinkus GS, Rollins BJ.Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis.Blood. 2003 Apr 1;101(7):2473-5.
    12642342
  • Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT.Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.Blood. 2003 Jul 1;102(1):262-8.
    12637319
  • Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ.Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.Cancer Cell. 2003 Feb;3(2):173-83.
    12620411
  • LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE.Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.J Clin Oncol. 2002 Jan 1;20(1):237-46.
    11773175
  • Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ.MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.Nat Genet. 2002 Jan;30(1):41-7.
    11731795
  • Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE.Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.Blood. 2001 Mar 1;97(5):1211-8.
    11222362
  • Cardoso AA, Veiga JP, Ghia P, Afonso HM, Haining WN, Sallan SE, Nadler LM.Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies.Blood. 1999 Nov 15;94(10):3531-40.
    10552964
  • Silverman LB, Gelber RD, Young ML, Dalton VK, Barr RD, Sallan SE.Induction failure in acute lymphoblastic leukemia of childhood.Cancer. 1999 Mar 15;85(6):1395-404.
    10189148
  • Asselin BL, Kreissman S, Coppola DJ, Bernal SD, Leavitt PR, Gelber RD, Sallan SE, Cohen HJ.Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia.J Pediatr Hematol Oncol. 1999 Jan-Feb;21(1):6-12.
    10029805
  • Kimball Dalton VM, Gelber RD, Li F, Donnelly MJ, Tarbell NJ, Sallan SE.Second malignancies in patients treated for childhood acute lymphoblastic leukemia.J Clin Oncol. 1998 Aug;16(8):2848-53.
    9704738
  • Nysom K, Holm K, Lipsitz SR, Mone SM, Colan SD, Orav EJ, Sallan SE, Olsen JH, Hertz H, Jacobsen JR, Lipshultz SE.Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.J Clin Oncol. 1998 Feb;16(2):545-50.
    9469339
  • Silverman LB, McLean TW, Gelber RD, Donnelly MJ, Gilliland DG, Tarbell NJ, Sallan SE.Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.Cancer. 1997 Dec 15;80(12):2285-95.
    9404706
  • Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, Ottlinger ME.Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.Circulation. 1997 Oct 21;96(8):2641-8.
    9355905
  • Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, Brunzell JD, Otvos JD, Sallan SE, Rifai N.Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.Blood. 1997 Mar 15;89(6):1886-95.
    9058708
  • McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR.TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.Blood. 1996 Dec 1;88(11):4252-8.
    8943861
  • Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM.Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.Blood. 1996 Jul 1;88(1):41-8.
    8704200
  • Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD, Colan SD.Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.N Engl J Med. 1995 Jun 29;332(26):1738-43.
    7760889
  • Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE.Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.J Clin Oncol. 1994 Apr;12(4):740-7.
    8151317
  • Gelber RD, Sallan SE, Cohen HJ, Donnelly M, Dalton V, Tobia F, Clavell LA, Tarbell NJ.Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.Cancer. 1993 Jul 1;72(1):261-70.
    8508416
  • Billett AL, Sallan SE.Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging.Am J Pediatr Hematol Oncol. 1993 May;15(2):162-8.
    8498641
  • Hays DM, Landsverk J, Sallan SE, Hewett KD, Patenaude AF, Schoonover D, Zilber SL, Ruccione K, Siegel SE.Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life.J Clin Oncol. 1992 Sep;10(9):1397-406.
    1517782